L2 Asset Management LLC Decreases Holdings in Lam Research Corporation $LRCX

L2 Asset Management LLC reduced its position in Lam Research Corporation (NASDAQ:LRCX) by 13.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,390 shares of the semiconductor company’s stock after selling 2,739 shares during the period. L2 Asset Management LLC’s holdings in Lam Research were worth $2,328,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of LRCX. Howard Hughes Medical Institute acquired a new stake in Lam Research in the second quarter valued at $27,000. Strategic Wealth Investment Group LLC purchased a new position in shares of Lam Research in the second quarter valued at $29,000. Delos Wealth Advisors LLC acquired a new position in shares of Lam Research during the 2nd quarter worth $30,000. Country Trust Bank purchased a new stake in shares of Lam Research in the 2nd quarter worth about $39,000. Finally, Sound Income Strategies LLC purchased a new stake in shares of Lam Research in the 3rd quarter worth about $41,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Lam Research news, insider Ava Harter sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total value of $333,990.00. Following the sale, the insider directly owned 53,205 shares of the company’s stock, valued at approximately $11,846,625.30. This trade represents a 2.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the sale, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 130,886 shares of company stock valued at $29,658,802 over the last quarter. Company insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

LRCX has been the subject of several recent research reports. Stifel Nicolaus raised their target price on shares of Lam Research from $250.00 to $280.00 and gave the company a “buy” rating in a report on Thursday, January 29th. KeyCorp reiterated a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. Argus raised their price objective on shares of Lam Research from $175.00 to $280.00 in a research note on Tuesday, February 3rd. Wells Fargo & Company lifted their price objective on Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Finally, Morgan Stanley upped their target price on Lam Research from $244.00 to $254.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 25th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and a consensus target price of $245.35.

Lam Research Stock Performance

NASDAQ:LRCX opened at $219.40 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The firm has a market cap of $273.98 billion, a PE ratio of 44.96, a P/E/G ratio of 2.28 and a beta of 1.77. The firm has a 50 day simple moving average of $225.24 and a 200-day simple moving average of $174.48. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $256.68.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s revenue was up 22.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is 21.31%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.